Dr. James M. Flynn Symposium on Advancing Cancer Care for Primary Care Proviers

Join us for the Dr. James M. Flynn Symposium on Advancing Cancer Care for Primary Care Providers on Friday, May 8 at the Sheraton Overland Park Hotel!

The symposium has been planned and designed to provide primary members of the healthcare team with the tools and knowledge they need to advance frontline oncology readiness. This includes enabling primary care physicians to proactively identify risk, optimize evidence-based screening, and confidently integrate emerging prevention and treatment pathways into everyday practice. This will drive early intervention and improve patient outcomes, as well as strengthen crosscontinuum care alignment. The goal is to equip Primary Care Providers with practical insights on evolving oncology standards, referral optimization, and survivorship coordination to enhance collaboration with specialty care and elevate the overall cancer care ecosystem.

Physicians can receive 6.75 continuing education credits. Nurses can receive 8.3 continuing education contact hours.

Sheraton Overland Park Hotel is located at 6100 College Blvd, Overland Park, KS 66211.

CME Credit Statement

CME Credit Statement

The Kansas City Southwest Clinical Society designates this live activity for a maximum of 6.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in this activity.
CNE Credit Statement

CNE Credit Statement

HCA MidAmerica Clinical Education is approved as a provider of continuing education in nursing by the Kansas State Board of Nursing. This course offering is approved for 8.3 contact hours for RN, LPN, or LMHT re-licensure. Kansas State Provider No. LT0312-1221. The course planners and presenters certify that they have no affiliations with, or involvement in, any organization or entity with any financial interest in the subject matter or materials discussed in this presentation.

Download the Brochure

FEATURED SPEAKERS

Andrew Rodriguez, MD

“Glioblastoma: Understanding the Most Aggressive Brain Tumor”
Dax Kurbegov, MD

“Multi-Cancer Early Detection”
Jaswinder Singh, MD

“Updates on Bispecific treatment”
Gina Shay-Zapien, APRN

“High-risk women’s program update”
Anis Toumeh, MD

“Endocrine therapy update”
Kelly Brazzle, FNP

“Panel: Breast, Colorectal, Lung Cancer Screening Update"
Benyamine Mizrahi, MD

“Panel: Breast, Colorectal, Lung Cancer Screening Update”
Brietta Forbes, MD

“Panel: Breast, Colorectal, Lung Cancer Screening Update”
Nicholas Wirtz, MD

“HPV and Head & Neck cancer update”
Michael Hughes, MD

“Update on the role of radiation therapy for benign disease”